tiprankstipranks
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
US Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports
Want to see EPRX full AI Analyst Report?

Eupraxia Pharmaceuticals (EPRX) Financial Statements

36 Followers

Eupraxia Pharmaceuticals Financial Overview

Eupraxia Pharmaceuticals's market cap is currently $473.95M. The company's EPS TTM is $-1.31; its P/E ratio is -7.90; Eupraxia Pharmaceuticals is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -241.88KC$ -235.25KC$ -209.91KC$ -193.27KC$ -111.53K
Operating IncomeC$ -39.11MC$ -36.99MC$ -36.90MC$ -22.63MC$ -20.87M
EBITDAC$ -38.86MC$ -33.72MC$ -37.40MC$ -22.14MC$ -21.96M
Net IncomeC$ -39.25MC$ -34.94MC$ -37.39MC$ -23.26MC$ -22.99M
Balance Sheet
Cash & Short-Term InvestmentsC$ 80.42MC$ 33.10MC$ 19.34MC$ 24.74MC$ 29.90M
Total AssetsC$ 85.99MC$ 50.24MC$ 26.72MC$ 25.88MC$ 31.22M
Total DebtC$ 154.08KC$ 103.31KC$ 10.45MC$ 10.55MC$ 9.49M
Net DebtC$ -80.26MC$ -33.03MC$ -11.72MC$ -14.19MC$ -11.40M
Total LiabilitiesC$ 5.69MC$ 4.46MC$ 25.55MC$ 14.51MC$ 11.67M
Stockholders' EquityC$ 81.89MC$ 33.40MC$ 2.22MC$ 12.86MC$ 20.39M
Cash Flow
Free Cash FlowC$ -29.65MC$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07M
Operating Cash FlowC$ -29.05MC$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64M
Investing Cash FlowC$ -599.26KC$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45M
Financing Cash FlowC$ 77.39MC$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

Income Statement >

Eupraxia Pharmaceuticals Debt to Assets

Balance Sheet >

Eupraxia Pharmaceuticals Cash Flow

Cash Flow >

Eupraxia Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >